Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LMO4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LINC00310 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GNB5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WBSCR22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00334 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928370 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHB15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAPGEF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SVOP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESYT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHGA8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GHRL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM213 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASAL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAPS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDPF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on